endocrine
PEDIATRIC ENDOCRINE SYSTEM — OVERVIEW OF THE PEDIATRIC ENDOCRINE SYSTEM
The pediatric endocrine system consists of:
Hormones
Glands
Organs
These elements work together to regulate:
Growth
Metabolism
Development
Homeostasis
Other vital body functions
Importance of the endocrine system in children:
Plays a major role in:
Normal growth
Brain development
Sexual maturation
Fluid balance
Blood glucose regulation
Overall physical and mental health
HOW THE ENDOCRINE SYSTEM FUNCTIONS
The endocrine system operates by releasing hormones that act as chemical messengers.
These hormones travel to:
Specific target organs
Tissues
Cells
Responses can either:
Stimulate a response
Inhibit a response
REGULATION OF HORMONES
Regulation occurs through feedback systems:
Positive feedback
Negative feedback
Positive and Negative Feedback
Negative Feedback
Most common endocrine control mechanism.
When adequate hormone is present, the body decreases further hormone release.
Aids in maintaining balance/homeostasis.
Example: If too much thyroid hormone is present, the pituitary decreases TSH release.
Positive Feedback
Hormone release causes more hormone stimulation or activity.
Less commonly used.
Tends to amplify a process.
HORMONES — KEY TERM DEFINITIONS
Hormones: Chemical substances produced by endocrine glands that stimulate or regulate organ function.
Hormones control many physiological responses, including:
Growth
Metabolism
Fight-or-flight response
Fluid regulation
Reproductive development
Calcium and glucose balance
They also help maintain:
Homeostasis
Normal body functioning
TWO TYPES OF HORMONES
Protein hormones: Made from amino acids.
Steroid hormones: Made from fats.
Hormone structure affects:
How hormones are made.
How they travel in the body.
How they act on target cells.
IMPORTANCE OF THE PEDIATRIC ENDOCRINE SYSTEM
Anomalies in the endocrine system can lead to severe conditions such as:
Growth hormone deficiency
Thyroid disorders
Diabetes
Endocrine disorders can significantly affect:
Height
Weight
Puberty
Metabolism
Cognition
Development
Overall health
Key nursing point: Early diagnosis and treatment are crucial for optimizing:
Growth
Development
Physical health
Mental health
MAJOR AREAS COVERED IN THIS SECTION
Focus on high-yield endocrine organs such as:
Pituitary system
Thyroid gland
Pancreas
ANATOMY AND PHYSIOLOGY OF THE PITUITARY SYSTEM
The pituitary gland is located at the base of the brain and divided into:
Anterior pituitary lobe
Posterior pituitary lobe
Each lobe has distinct functions.
ANTERIOR PITUITARY LOBE
Responsible for releasing:
Growth hormone (GH)
Adrenocorticotropic hormone (ACTH)
Thyroid-stimulating hormone (TSH)
Luteinizing hormone (LH)
Follicle-stimulating hormone (FSH)
Prolactin
Each is critical and commonly tested.
POSTERIOR PITUITARY LOBE
Secretes:
Oxytocin
Antidiuretic hormone (ADH)
KEY TERM DEFINITIONS — PITUITARY HORMONES
Growth hormone (GH): Secreted by the anterior pituitary; stimulates and regulates growth.
Adrenocorticotropic hormone (ACTH): Stimulates cortisol production.
Thyroid-stimulating hormone (TSH): Stimulates the thyroid to release thyroid hormones.
Luteinizing hormone (LH): Induces ovulation in ovaries.
Follicle-stimulating hormone (FSH): Promotes egg and sperm production.
Prolactin: Stimulates lactation by the mammary glands.
Antidiuretic hormone (ADH): Controls water and salt balance in the body.
ADH AND FLUID REGULATION
ADH is essential for fluid balance.
Source: Produced by the hypothalamus, stored in the pituitary gland until needed.
Triggers for ADH release: If there is too little water in the body, the pituitary releases ADH.
Function: ADH promotes water retention in the kidneys, helping to maintain fluid balance, blood volume, and homeostasis.
KEY TERM DEFINITION — HYPOTHALAMUS
Hypothalamus: The primary control center for the autonomic nervous system, regulates:
Sleep cycles
Body temperature
Appetite
Produces hormones that regulate pituitary hormone secretion, critical since the hypothalamus and pituitary form a regulatory unit.
PITUITARY HORMONE TARGETS AND FUNCTIONS
Hormones | Target | Function |
|---|---|---|
ACTH | Adrenal glands | Stimulates adrenal glands to produce cortisol. |
TSH | Thyroid gland | Stimulates thyroid to secrete thyroxine. |
LH and FSH | Ovaries/Testes | Regulate reproductive function; influence sexual characteristics. |
Prolactin (PRL) | Breasts | Stimulates milk production (higher during pregnancy). |
Growth Hormone (GH) | All cells in the body | Affects growth and repair throughout the body. |
ADH | Kidneys | Promotes water retention. |
Oxytocin | Uterus/Breasts | Controls uterine contractions during pregnancy; milk release after birth. |
ANATOMY AND PHYSIOLOGY OF THE THYROID GLAND
The thyroid gland is:
Butterfly-shaped
Located on the anterior side of the throat, just below the larynx.
Structure:
Comprises two lobes (each about 2 inches long) on either side of the trachea, connected by the isthmus.
THYROID CELL TYPES
Follicular cells
Secrete iodine-containing thyroid hormones: Thyroxine (T4) and Triiodothyronine (T3).
Parafollicular cells
Produce calcitonin (lowers blood calcium levels).
IMPORTANT THYROID PHYSIOLOGY
Follicular cells absorb iodine to produce T3 and T4;
Parafollicular cells do not absorb iodine; produce calcitonin instead.
FUNCTIONS OF T3 AND T4
Thyroid hormones T3 and T4 affect virtually every tissue in the body and help:
Produce proteins
Increase oxygen use
Regulate metabolism
Influence:
Heart rate
Body temperature
Energy use
Growth
Brain development
Especially critical for brain growth and development in young children (an ATI/NCLEX concept).
TSH AND THYROID FEEDBACK SYSTEM
Regulated by TSH from the pituitary via a negative feedback loop:
If thyroid hormone levels are too high, the pituitary decreases TSH, slowing production.
If thyroid hormone levels are too low, the pituitary increases TSH, stimulating the thyroid.
ANATOMY AND PHYSIOLOGY OF THE PANCREAS
The pancreas is:
An elongated organ, located behind the stomach.
Structure:
Right side is called the head (widest part, curves with the duodenum).
Left side is the tail (extends towards the spleen).
PANCREAS FUNCTIONS
Two major functions:
Exocrine function: Aids in digestion.
Endocrine function: Regulates blood glucose, particularly significant in pediatric endocrine disorders (e.g., diabetes).
ISLETS OF LANGERHANS
The endocrine cells of the pancreas are the islets of Langerhans, producing hormones regulating blood glucose.
PRIMARY PANCREATIC HORMONES
Insulin: Lowers blood glucose levels.
Glucagon: Raises blood glucose levels.
The balance between insulin and glucagon is critical for glucose homeostasis.
HIGH-YIELD CLINICAL CONNECTIONS
Endocrine disorders can lead to specific conditions:
Growth hormone disorders can result in:
Poor growth
Delayed development
Thyroid disorders can lead to:
Altered metabolism
Growth issues
Cognitive effects
Changes in temperature regulation and heart rate.
Diabetes/pancreatic disorders cause:
Hyperglycemia
Hypoglycemia
Metabolic instability.
NURSING IMPORTANCE IN PEDIATRIC ENDOCRINE DISORDERS
Nurses must understand:
Gland function
Hormonal effects
Feedback loops
Growth and development implications
Treatment priorities
Patient education needs
Nursing priorities include:
Growth monitoring
Developmental assessments
Medication administration
Family education
Promoting adherence
Monitoring for complications
Supporting long-term health outcomes.
KEY TERM DEFINITIONS — QUICK LIST
Hormones: Chemical substances produced by endocrine glands regulating organ function.
Growth hormone (GH): Anterior pituitary hormone stimulating growth.
Adrenocorticotropic hormone (ACTH): Pituitary hormone stimulating cortisol production.
Thyroid-stimulating hormone (TSH): Pituitary hormone stimulating thyroid hormone release.
Luteinizing hormone (LH): Pituitary hormone involved in ovulation and reproductive function.
Follicle-stimulating hormone (FSH): Pituitary hormone for egg and sperm production.
Prolactin: Hormone stimulating milk production.
Antidiuretic hormone (ADH): Causes kidneys to retain water.
Hypothalamus: Regulates autonomic functions and pituitary hormone secretion.
Calcitonin: Lowers blood calcium.
Thyroxine (T4): Affects metabolism and functionality in the body.
Triiodothyronine (T3): Regulates metabolism and oxygen use.
Islets of Langerhans: Endocrine pancreas regulating blood glucose.
Insulin: Lowers blood glucose.
Glucagon: Raises blood glucose.
HIGH-YIELD ATI / NCLEX TAKEAWAYS
The endocrine system regulates:
Growth
Metabolism
Homeostasis
Development
Hormones act as chemical messengers.
Endocrine control uses positive and negative feedback.
Hormones are either protein or steroid-based.
The pituitary gland has anterior and posterior lobes:
Anterior releases:
GH
ACTH
TSH
LH
FSH
Prolactin
Posterior releases:
Oxytocin
ADH
ADH, made by the hypothalamus and stored in the pituitary, acts on kidneys for water retention.
The thyroid gland is butterfly-shaped, located below the larynx:
Follicular cells produce T3 and T4;
Parafollicular cells produce calcitonin.
T3 and T4 impact almost every tissue, critical for brain development in children.
TSH regulates thyroid hormones via negative feedback.
The pancreas has both exocrine and endocrine functions,
Islets of Langerhans regulate blood glucose levels.
Insulin lowers and glucagon raises blood glucose.
Endocrine disorders in children can severely impact growth and development, making early diagnosis and intervention crucial.
PITUITARY DISORDERS — OVERVIEW
Pituitary disorders involve hormonal imbalances affecting:
Growth
Mood
Behavior
Metabolism
Puberty
Fluid balance
Target-organ function
The pituitary gland’s impact varies based on:
Hormones (overproduced or underproduced)
Congenital vs. acquired conditions
Causes (tumor, trauma, etc.)
Important concept: The pituitary gland affects multiple target organs, leading to diverse manifestations.
Example Manifestations of Pituitary Disorders
Unexplained weight changes
Vision impairment from optic nerve pressure
Abnormal growth due to GH regulation changes
Mood fluctuations
Pubertal discrepancies
Fluid imbalance
Other Causes of Endocrine Disruptions
Brain trauma
Bleeding near the pituitary gland
Medication effects
Cancer treatment side effects
GROWTH HORMONE DEFICIENCY (GHD) PATHOPHYSIOLOGY
GH is essential for:
Normal linear growth
Muscle and bone development
Normal body fat distribution
It regulates:
Glucose levels
Lipid levels
Without adequate GH, a child grows more slowly than peers and may not reach full adult height.
Types of GHD
Congenital GHD: Present at birth.
Acquired GHD: Develops after birth due to:
Brain injury
Surgery
Tumor
Chemotherapy
Radiation.
ETIOLOGY AND RISK FACTORS FOR GHD
Root causes:
Damage or dysfunction of the pituitary gland.
Can stem from:
Fetal genetic mutations
Genetic syndromes
Head trauma
Infections
Stroke.
Important inherited conditions:
Multiple endocrine neoplasia type 1 (MEN 1)
Familial isolated pituitary adenoma (FIPA).
Children at elevated risk due to factors like:
Family history of pituitary disorders
Brain injury
Genetic anomalies
Infections (e.g., meningitis)
Cancer treatments.
EPIDEMIOLOGY
Data on pediatric pituitary disorders is limited.
Most common hormone deficiency: Growth hormone deficiency (prevalence: 1 in 3,480 children).
Pituitary tumors account for 3% - 6% of childhood brain tumors and often develop during puberty.
Most frequently affects females and impacts growth patterns.
Cancer treatments can impede growth; up to 20% experience related pituitary abnormalities.
CLINICAL PRESENTATION OF GHD
Symptoms may arise quickly post-trauma or progress slowly if congenital.
Typically misdiagnosed as other conditions.
GHD Characteristics in Children:
Proportions usually expected.
Weight may be within the normal range.
Height shorter than expected with a drop in percentiles over time.
Most crucial assessment finding: Height velocity.
KEY TERM DEFINITION — HEIGHT VELOCITY
Measure of the speed of growth in height over time.
Essential indicator in suspected GHD situations.
Providers need to closely observe annual growth charts and gather detailed medical histories for analysis of growth patterns.
LABORATORY TESTING AND DIAGNOSTIC STUDIES FOR GHD
Testing centers on the growth pattern. If growth charts reveal:
Decreased height velocity without malnutrition or injury, further testing is warranted.
Indicators of decreased height velocity based on ages:
Ages 2 to 4: less than 5.5 cm/year.
Ages 4 to 6: less than 5 cm/year.
Ages 6 to Puberty: less than 4 to 4.5 cm/year.
Bone age x-ray: Compares skeletal maturation against chronological age by viewing the hand and wrist x-ray.
MRI: Rule out pituitary injury, brain injury, tumors, or other structural causes.
Blood work: Helps eliminate other conditions and measures growth factor levels.
GH stimulation test: Medications stimulate the pituitary to induce GH release.
Interpretation: Insufficient GH rise signals potential underproduction by the pituitary.
GROWTH HORMONE BLOOD LEVELS — Reference Ranges
Newborn: 5 to 23 ng/mL
1 Week: 2 to 27 ng/mL
1 to 12 Months: 2 to 10 ng/mL
Older than 1 Year (Female): 0 to 10 ng/mL
Older than 1 Year (Male): 0 to 6 ng/mL
GH Suppression: less than 2 ng/mL
GH Stimulation: greater than 10 ng/mL
INSULIN-LIKE GROWTH FACTOR-I (IGF-I)
IGF-I is also significant for evaluating growth concerns.
Male IGF-I reference ranges:
0 to 8 years: 2 to 118 ng/mL
9 to 10 years: 15 to 148 ng/mL
11 to 13 years: 55 to 216 ng/mL
14 to 15 years: 114 to 232 ng/mL
16 to 17 years: 84 to 211 ng/mL
18 to 19 years: 56 to 177 ng/mL
Female IGF-I reference ranges:
0 to 8 years: 5 to 128 ng/mL
9 to 10 years: 24 to 158 ng/mL
11 to 13 years: 65 to 226 ng/mL
14 to 15 years: 124 to 242 ng/mL
16 to 17 years: 94 to 231 ng/mL
18 to 19 years: 66 to 186 ng/mL
ORAL GLUCOSE TOLERANCE EXPECTED RANGES
Fasting: less than 110 mg/dL
1 Hour: less than 180 mg/dL
2 Hour: less than 140 mg/dL
3 Hour: 70 to 115 mg/dL
4 Hour: 70 to 115 mg/dL
TREATMENT OF GHD
Children with GHD require:
Daily injections of synthetic human growth hormone.
Administration: Subcutaneously, preferably at bedtime due to peak release during sleep.
Education: Nurses instruct parents and, if age-appropriate, children on proper GH administration.
Follow-up priorities: Monitor for:
Appropriate growth response
Ongoing bone age progression
Adverse effects
Treatment effectiveness
Expected response: Anticipated growth is approximately 4 inches within the first year of GH therapy.
Duration of treatment: Continues until:
Growth plates close,
Full adult height is achieved.
COMMON ADVERSE EFFECTS
Typically minor effects related to rapid growth:
Muscle pain
Joint pain
Hand/foot swelling.
Rare but critical:
Severe headache
Vision problems
Hip issues — report immediately.
IMPACT OF GHD ON OVERALL HEALTH
Psychosocial Impact
Children may experience:
Low self-esteem
Poor confidence
Body image issues
Depression
Anxiety
Children may internalize issues more frequently.
Developmental Impact
GHD may lead to:
Cognitive impairments
Poor school performance
Reduced intellectual function compared to peers.
PEDIATRIC CONSIDERATIONS FOR GHD
If untreated, a child may never reach their adult height potential.
Important point: Early treatment results in better outcomes — a classic early-intervention endocrine principle.
HEALTH PROMOTION AND DISEASE PREVENTION FOR GHD
Given that endocrine disorders can mimic other diseases, early diagnosis becomes vital.
Children with GHD require:
Regular follow-ups
Growth monitoring
Hormone level tracking
Treatment adjustments as necessary.
PRECOCIOUS PUBERTY / DELAYED PUBERTY PATHOPHYSIOLOGY
These conditions relate to imbalances in the hypothalamic-pituitary-gonadal (HPG) axis.
KEY TERM DEFINITION
Hypothalamic-pituitary-gonadal (HPG) axis: Hormonal regulatory system managing reproductive activities.
Precocious puberty: Begins earlier than expected.
Delayed puberty: Lack of expected pubertal developments at the appropriate age.
Early puberty may manifest as:
Initially tall stature but halted growth leads to shorter adult height.
ETIOLOGY AND RISK FACTORS FOR DELAYED PUBERTY
Higher risk in children with:
Chronic illnesses
Nutritional deficiencies
Congenital anomalies.
EPIDEMIOLOGY
Pituitary-related disorders (like precocious puberty) are more frequently noted in females compared to males.
CLINICAL PRESENTATION OF PRECOCIOUS PUBERTY
Current guideline nuance: Puberty is labeled precocious when:
Breast development or pubic hair appears before age 7 in non-Hispanic White females.
Before age 6 in African American females.
Traditional definition: Puberty onset before:
Age 8 in females.
Age 9 in males.
Signs of Female Puberty Onset
First signs:
Breast enlargement
Breast buds
Typically followed by:
Pubic hair
Axillary hair
Body odor
Menarche begins about 2 years post breast bud development.
Signs of Precocious Puberty in Males
First signs:
Testicular enlargement (often subtle).
Later signs:
Growth in the penis and scrotum.
CLINICAL PRESENTATION OF DELAYED PUBERTY
In females, consider delayed puberty if:
No breast development by age 13
More than 4-year delay to menarche post-breast bud development
No menarche by age 16.
In males, delayed puberty to note if:
No testicular enlargement by age 14.
LABORATORY TESTING AND DIAGNOSTICS FOR PUBERTAL DISORDERS
Best Screening Tests
LH and FSH:
Levels exceeding expectations suggest precocious puberty.
Levels below expectations suggest delayed puberty.
LH expected findings (ages 1-10):
Females: 0.03 to 3.9 IU/L
Males: 0.04 to 3.6 IU/L
FSH expected findings for ages 1-10:
Females: 0.68 to 6.7 IU/L
Males: 0.3 to 4.6 IU/L.
TESTING — TESTOSTERONE
Useful in males suspected of precocious puberty:
Prepubertal: less than 30 ng/dL
Early pubertal: 30 to 100 ng/dL
Mid-late pubertal: 100 to 300 ng/dL
Adult: more than 300 ng/dL.
Estradiol may elevate in girls with precocious puberty, but reliability is lower.
Bone age x-ray: Used for both conditions; significant if bone age is 2 years or more less than chronological age.
MRI and hormone testing may also determine the cause.
TANNER STAGING OF PUBERTY
Stage 1: Males
No pubic hair, testicular volume less than 4 mL.
Stage 1: Females
No pubic hair, no palpable glandular breast tissue.
Stage 2: Males
Downy hair, testicular volume 4 to 8 mL.
Stage 2: Females
Downy hair, breast bud palpable under areola.
Stage 3: Males
Scant terminal hair, testicular volume 9 to 12 mL.
Stage 3: Females
Scant terminal hair, breast tissue palpable beyond the areola.
Stage 4: Males
Terminal hair covers entire pubic region, testicular volume 15 to 20 mL.
Stage 4: Females
Terminal hair covers entire pubic region, areola elevated above breast contour ("double scoop").
Stage 5: Males
Pubic hair crosses inguinal crease to thigh, testicular volume greater than 20 mL.
Stage 5: Females
Pubic hair crosses inguinal crease to thigh, protruding nipple, areola hyperpigmentation.
This chart is crucial.
TREATMENT OF PRECOCIOUS PUBERTY
Treatment is initiated with GnRH agonists.
Goal:
Postpone pubertal progression.
Most effective when:
Started before age 10 and continued for 12 months.
Follow-ups every 4 to 6 months with regular lab work.
Treatment goals:
Normalize height velocity.
Stop or slow breast growth in girls.
Suppress gonadotropin levels.
MEDICATION: LEUPROLIDE
Class: GnRH agonist.
Action: Reduces LH and FSH secretion.
Usage: Administered when sexual maturity starts in:
Girls younger than 8.
Boys younger than 9.
Adverse effects:
Headache
General pain
Hot flashes
Sweating
Urinary problems
Joint disorders.
Contraindications include:
Medicines like amiodarone and fluoxetine.
Client teaching:
Monitor response via GnRH stimulation test, basal LH, sex steroid levels.
Report psychiatric changes (e.g., anger, irritability).
TREATMENT OF DELAYED PUBERTY
Depends on the cause:
Malnutrition: Refer to a registered dietitian.
Chronic disease: Management adjustments by the healthcare team.
Endocrine hormonal issues: Low-dose testosterone for males, estrogen for females.
Monitor closely to ensure puberty begins; GHD may be initiated if concerns arise related to height/stature.
IMPACT OF PUBERTAL DISORDERS ON OVERALL HEALTH
Psychosocial Impact
Accelerated or delayed puberty increases risks for:
Adverse psychosocial developments
Stigmas
Emotional distress.
These effects may be exacerbated despite the medical severity.
Developmental Outcomes
May contribute to future issues:
Physical development challenges
Emotional development difficulties
Psychosocial complications
Health disorders later on.
PEDIATRIC CONSIDERATIONS FOR PUBERTAL DISORDERS
Children may encounter:
Stigma
Bullying
Negative peer interactions
Distress stemming from feelings of being “different.”
Family dynamic issues include:
Difficulties in explaining the condition to others
Emotional stress management.
HEALTH PROMOTION AND DISEASE PREVENTION FOR PUBERTAL DISORDERS
Children with pubertal disorders require:
Close hormone monitoring
Treatment adjustments as necessary.
Nutritional Considerations:
If delayed puberty relates to nutritional deficiencies, ensure diet includes:
Vitamins
Minerals
Whole foods
Sufficient protein intake.
HYPOPITUITARISM / HYPERPITUITARISM PATHOPHYSIOLOGY
Hypopituitarism: It's characterized by inadequate hormonal production by the pituitary gland, including deficiencies in one or more hormones.
Hyperpituitarism: Involves excessive hormone overproduction.
Manifestations vary based on the hormones impacted and the effects on target organs.
ETIOLOGY AND RISK FACTORS
Hypopituitarism
Can be congenital or acquired due to:
Pituitary injury
Tumor
Gene mutation
Any disruption in hormone release.
Hyperpituitarism
Rarely occurs in children, usually caused by a tumor leading to oversecretion of hormones.
EPIDEMIOLOGY
Most common hypopituitarism form: Growth hormone deficiency (GHD), with an incidence of 1 in 3,480 children.
Multiple hormone deficiency cases are rare (fewer than 3 cases per million each year in the U.S.).
Hypopituitarism can occur across the lifespan because it may be congenital or acquired.
CLINICAL PRESENTATION OF HYPOPITUITARISM
Neonates: May Show
Micropenis
Hypoglycemia
Jaundice
KEY TERM DEFINITIONS
Hypoglycemia: Low blood glucose.
Jaundice: Yellowing of skin and sclera due to elevated bilirubin.
Pallor: Pale appearance of skin.
Cyanosis: Bluish discoloration caused by low oxygenation, typically noted in lips and mucous membranes.
Important Neonatal Assessment Cues
Watch for signs of hypoglycemia:
Lethargy
Jitteriness
Pallor
Cyanosis
These may overlap with signs of other issues such as thermoregulation or infection.
Infant and Older Child Findings
Growth failure: Below the third percentile,
Delayed tooth development.
In later childhood/adolescence, delayed puberty may also present symptoms.
CLINICAL PRESENTATION OF HYPERPITUITARISM
Rare in children but may show:
Decreased estrogen in assigned female at birth individuals
Delayed puberty across all sexes
Upper body fat accumulation
Increased facial hair
Easy bruising and manifestations of hypercortisolism.
Acromegaly / Excess GH May Cause:
Enlarged hands, feet, or excessive height (> 7 feet).
LAB TESTING AND DIAGNOSTICS FOR HYPOPITUITARISM
If symptoms cannot be assigned to other disorders, additional tests are necessary.
ACTH stimulation + Cortisol stimulation tests evaluate adrenal responses and indirectly assess the hypothalamic-pituitary unit.
Interpretation: Cortisol being 20 mcg/dL excludes hypopituitarism.
Infant electrolyte disturbances may reveal sodium abnormalities not explained by fluid loss and low potassium levels.
TREATMENT OF HYPOPITUITARISM
Tailored based on the hormones lacking:
May require replacement of hormones tied to ACTH, TSH, LH, FSH, and GH.
Growth hormone replacement is essential in hypopituitarism episodes; surgery might be necessary when tumors are causative.
HYPERPITUITARISM
Treatment focuses primarily on surgical removal of the pituitary cause if present.
Symptoms include:
Weight gain
Hypertension
Acne
Fatigue
Depression
Exaggerated height gain (may lead to obesity and menstrual changes) and skin tags.
IMPACT ON OVERALL HEALTH
Psychosocial and Developmental Effects of Pituitary Disorders
Developmental, educational, and peer-related challenges emerge due to emotional and physical health struggles.
Psychological assistance is recommended for pediatric patients to encourage inclusion and timely milestone achievement.
PEDIATRIC CONSIDERATIONS
Maintaining alignment with developmental and social milestones is vital due to periods of rapid growth and social changes.
HEALTH PROMOTION AND DISEASE PREVENTION
Focus on:
Lifestyle management
Dietary habits
Obesity management
Regular monitoring of overall health metrics.
DIABETES INSIPIDUS (DI) PATHOPHYSIOLOGY
DI is a rare disorder due to:
Dysfunction in the pituitary/hypothalamic functions affecting ADH.
DI must be distinguished from diabetes mellitus:
DI Common Symptoms: Polydipsia and polyuria.
Key term definitions:
Polydipsia: Excessive thirst.
Polyuria: Excessive urination.
Mechanisms Behind DI
Excessive fluid loss occurs primarily due to:
Central DI: Inadequate ADH production by the hypothalamus; failure to release ADH by the pituitary.
Nephrogenic DI: Renal resistance to ADH function.
LAB TESTING AND DIAGNOSTIC STUDIES FOR DI
Initial Blood Work May Show
Increased hemoglobin and hematocrit levels, sodium, and potassium levels.
Urinalysis: will display very low specific gravity due to dilute urine.
MRI: Used to evaluate structural issues within the hypothalamus and pituitary.
WATER DEPRIVATION TEST
Purpose: Evaluates how the body reacts to no fluid intake to classify as central or nephrogenic DI.
During testing:
Intake is halted for several hours, while measuring urine output, urinalysis, and blood for ADH levels.
Key interpretation:
A greater than 9% increase in urine osmolality indicates central DI, while less than 9% suggests nephrogenic DI.
Administering ADH will show if the child stops urinating (indicating central DI) or continues (indicating nephrogenic DI).
Nursing Roles During Testing
Implement strict fluid restrictions per orders.
Monitor hourly urine output and body weight, reporting significant decreases greater than 2 kg.
TREATMENT OF DI
Primary Objective
Determine whether DI is central or nephrogenic:
Central DI treatment involves:
Desmopressin (DDAVP).
Nephrogenic DI treatment may include:
Thiazide diuretics or a low-solute diet alongside fluid intake monitoring.
MEDICATION: DESMOPRESSIN (DDAVP)
Type: Vasopressin analog.
Action: Increased water permeability reduces urine volume and increases osmolality.
Indications: Effective for central DI or transient polyuria after pituitary-region head trauma.
Side effects:
Dry mouth
Headache
Hyponatremia
Arrhythmias; monitor for severe effects like mood changes.
Administer intranasally, ensuring patients know to avoid excessive fluid intake before bedtime.
MEDICATION: AMILORIDE
Classified under thiazide diuretics, but retains potassium-sparing characteristics.
Action: Increases urine osmolality, decreasing urine volume and frequency.
Considerations: Monitoring of potassium levels is necessary.
IMPACT OF DI ON OVERALL HEALTH
Psychosocial Factors
Affected children may experience embarrassment, anxiety, and disruption of daily life due to incontinence and nocturia, leading to increased self-awareness.
Parents must be informed of the conditions as children may fail to recognize symptoms.
Developmental Impact
DI diagnoses place children at risk of hyperactivity, learning delays, and psychomotor developmental delays, necessitating continuous support and monitoring.
PEDIATRIC CONSIDERATIONS FOR DI
Effective management includes:
Close monitoring of health status
Adjustments to treatment plans to provide support.
Children may benefit from reminders about fluid intake and monitoring.
HEALTH PROMOTION AND DISEASE PREVENTION FOR DI
Emphasize educating about:
Fluid intake/output tracking
Signs of dehydration and when to prepare for emergencies.
Electrolyte imbalances can escalate; hence, home monitoring is vital.
ROLE OF THE NURSE IN PITUITARY DISORDERS
Nurses are vital in:
Assessment, treatment management, education, and advocacy efforts.
Assessment duties include:
Detailed history taking and focus on endocrine manifestations.
Hospital Responsibilities Include
Medication administration, monitoring vital signs, lab results, dietary needs, and supporting nutrition.
EDUCATION RESPONSIBILITIES
Educating parents and children regarding:
Medication administration techniques
Adverse effect recognition
Normal development expectations.
INDIVIDUAL FACTORS / SELF-CARE SKILLS
Teaching self-care improves outcomes; children should:
Learn to manage activities of daily living (ADLs).
Make healthy nutrition decisions.
Administer medications as age-suitable.
PLAY, COMMUNICATION, SOCIALIZATION, SEXUALITY
Play:
Essential in nourishing development and comprehension of illness management.
Communication:
Essential for expressing emotions about differences and sharing concerns.
Encourage open discussions and honesty during care visits.
Socialization:
Promote opportunities for play and interaction with peers to reduce stress and isolation risks.
Sexuality:
Address pubertal disorders and their influence on sexuality, providing family support through open communication.
CLIENT EDUCATION
Education should span from admission, throughout discharge, into home care focusing on:
Disorder understanding
Treatment plans
Monitoring for potential complications.
Healthy lifestyle practices.
ENVIRONMENTAL TOXINS / ENDOCRINE DISRUPTORS
Educate families on environmental factors such as:
Arsenic
Lavender oil
Tea tree oil
Atrazine
Bisphenol A (BPA)
Phytoestrogens.
Presence in:
Food, beverages, and household products.
Potential effects:
Hormonal disruptions leading to metabolism and growth issues, impacting puberty timing.
HIGH-YIELD ATI / NCLEX TAKEAWAYS
Pituitary disorders lead to hormonal imbalance affecting:
Growth, mood, behavior, puberty, metabolism, and target organs.
GHD is the most common pituitary hormone deficiency in pediatric patients.
Key GHD assessment metric = height velocity;
Decrease thresholds for various ages noted.
Protocols for GHD workup involve growth chart reviews and imaging to assess bone age.
GH therapy administered subcutaneously at bedtime continues until growth plates are ossified.
Adverse effects from GH therapy include headaches and vision problems.
Precocious puberty definition shifted to onset nuances.
Delayed puberty standards focus on specific ages for development milestones.
Precocious puberty treatments center around GnRH agonist leuprolide.
Hypopituitarism signifies insufficient hormonal production, while hyperpituitarism denotes overproduction.
Neonatal hypopituitarism clues include micropenis or hypoglycemia.
Distinguish diabetes insipidus from diabetes mellitus by differentiating polyuria due to ADH problems.
Central DI treatment involves desmopressin, whereas nephrogenic DI focuses on alternative regimens.
Nurses play crucial roles in monitoring labs, patient education, and psychosocial support throughout treatment.
KEY TERM DEFINITIONS — QUICK LIST
Height velocity: Rate of height growth over time.
Hypothalamic-pituitary-gonadal (HPG) axis: Governs reproductive function.
Hypoglycemia: Low glucose levels.
Jaundice: Yellowing due to bilirubin buildup.
Cyanosis: Blue discoloration from oxygen deprivation.
Polydipsia: Excessive thirst.
Polyuria: Excessive urination.
Central DI: Insufficient ADH supply.
Nephrogenic DI: Renal resistance to ADH effects.
GnRH agonist: Drug suppressing gonadotropin secretion.
THYROID DISORDERS — OVERVIEW OF THYROID FUNCTION
The thyroid gland requires iodine to synthesize:
T4 (Thyroxine)
T3 (Triiodothyronine).
Sources of iodine are from dietary intake and thyroid hormones' metabolic processes.
FUNCTION OF THYROID HORMONES
T3 and T4 regulate:
Metabolism
Growth
Energy production
Temperature regulation
Brain development, especially critical in infants.
KEY CONCEPT: FEEDBACK LOOP
Pituitary releases TSH → stimulates thyroid release of T3/T4.
High T3/T4 levels lead to decreased TSH (negative feedback mechanism).
TYPES OF THYROID DISORDERS
Congenital: Present from birth.
Acquired: Develop over time.
HYPOTHYROIDISM
KEY TERM
Hypothyroidism: Deficient thyroid hormone production (low T3 and T4).
PATHOPHYSIOLOGY
Low T3/T4 levels lead to a hypometabolic state.
LAB PATTERNS
Primary Hypothyroidism
T3/T4: Decreased;
TSH: Increased due to pituitary compensation.
Central Hypothyroidism
T3/T4: Decreased;
TSH: Decreased or normal, signifying a pituitary or hypothalamic problem.
CONGENITAL HYPOTHYROIDISM (CH)
Causes
Most common:
Agenesis (absence of thyroid).
Dysplasia (abnormal development).
Ectopy (abnormal location).
Additional causes may involve impaired T4 synthesis, iodine metabolism disorders, and specific autosomal recessive disorders.
ACQUIRED HYPOTHYROIDISM
Causes
Primarily due to autoimmunity (e.g., Hashimoto's disease) where the immune system attacks the thyroid.
Iatrogenic causes might involve surgical removal or radiation.
Central hypothyroidism is rare, associated with insufficient TSH production by the pituitary.
SCREENING FOR HYPOTHYROIDISM
Newborn screening is mandated in the United States, measuring T4 levels.
Caution: Can miss some cases; monitoring symptoms is crucial.
Follow-up testing includes:
Total T4 + TSH assessment.
Imaging techniques:
Radionuclide scan or ultrasound for structure assessment.
ETIOLOGY OF HYPOTHYROIDISM
Most cases arise from thyroid dysgenesis, not hereditary traits.
Global Concept: Iodine deficiency is a common worldwide cause but rare in wealthier nations due to iodized salt use.
RISK FACTORS
Positive history of:
Family thyroid disease
Twin births
Maternal age >35 years
Preterm birth
Iodine deficiency
EPIDEMIOLOGY OF HYPOTHYROIDISM
Significantly common pediatric endocrine disorder with incidence rates of 1 in 3,000–4,000 births. Higher risk in Hispanic and Asian infants; lower risk in African American infants.
CLINICAL PRESENTATION
Often asymptomatic early; signs may be subtle:
EARLY MANIFESTATIONS OF CONGENITAL HYPOTHYROIDISM MAY INCLUDE
High birth weight
Delayed stooling
Poor feeding
Hoarse cry
Noisy breathing
Jaundice.
ACQUIRED HYPOTHYROIDISM SIGNS INCLUDE
Weight gain
Goiter
Slow growth
Delayed bone age
Dry skin
Sleep apnea
Galactorrhea
Sexual pseudo-precocity.
SHARED SYMPTOMS FROM BOTH TYPES INCLUDE
Constipation
Lethargy
Cold intolerance/hypothermia.
KEY TERMS FOR SIGNIFICANT SYMPTOMS
Galactorrhea: Milk production without pregnancy.
Sexual pseudo-precocity: Abnormal secretion of sex hormones.
IMPORTANT TIMING
Congenital symptoms typically emerge after 6 weeks due to maternal hormone transfer.
LATE MANIFESTATIONS (IF UNTREATED):
Hypotonia
Large fontanels
Jaundice
Large tongue
Dry and cold skin
Abdominal distention
Umbilical hernias
Bradycardia
Hypotension
Anemia
Coarse facies.
KEY TERM
Coarse facies: Thickened facial features noted for less-defined facial features.